Oncology & Cancer

Immunotherapy improves survival in advanced bladder cancer patients

An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...

Other

Gilead in $21 bn deal for Immunomedics

US pharmaceutical giant Gilead Sciences confirmed Sunday that it is buying American biotech firm Immunomedics, which makes a breast cancer drug, for $21 billion.

Medical research

Scientists recreate DNA damage caused by toxins from smoking

Researchers from the University of York have recreated how toxins from smoking cause unique patterns of DNA damage. The discovery could help scientists better understand the cause of bladder cancer and the link to smoking.

page 12 from 39